Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Nashville Biosciences Launches


 
Leeland Ekstrom, PhD

VUMC Harnesses Power of Genomic, Bioinformatics Resources

Last month, officials with Vanderbilt University Medical Center (VUMC) announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

Through Nashville Biosciences, pharmaceutical and other life science companies can leverage the wealth of data contained within VUMC's genomics and health information technology resources to accelerate the discovery and development of new treatments for patients, while helping to support institutional research efforts.

"Partnering with the pharmaceutical and broader life sciences industry through Nashville Biosciences will enable VUMC to expand and support its mission of advancing translational and precision medicine," said Leeland Ekstrom, PhD, founder and chief operating officer of Nashville Biosciences.

The new company will serve as a commercial interface between outside companies and the formidable research resources housed in VUMC, including its comprehensive databank BioVU® which contains more than 250,000 DNA samples collected over the last decade, coupled with 2.8 million de-identified patient records.

"The creation of Nashville Biosciences will dramatically accelerate our ability to work with pharmaceutical and other partners to advance human health by accelerating rational drug and diagnostics development and use," added Dan Roden, MD, VUMC's senior vice president for Personalized Medicine.

Among the capabilities that will distinguish the company are analytical methods developed for "mining" DNA datasets. For example, researchers led by Josh Denny, MD, MS, vice president of Personalized Medicine, have pioneered techniques such as PheWASTM that can link specific genetic mutations to their key clinical characteristics (known as disease phenotypes).

Among academic medical centers, VUMC is widely recognized as a leader in the application of genomics and bioinformatics to drug development, an effort that is transforming the pharmaceutical industry, Ekstrom said. Even before the launch of Nashville Biosciences, VUMC has already been working closely with a number of top pharmaceutical and diagnostic companies including Pfizer, Celgene Corporation, Population Bio, and Goldfinch Bio. These projects, each of which aims to discover new treatments for patients in disease areas of interest for each partner, as well as multiple other ongoing efforts, will transition to the new company in the coming weeks.

"We've only just started to scratch the surface of what is possible with genomics and informatics resources that can be coalesced for research in a comprehensive academic medical center," said Gordon Bernard, MD, executive vice president for Research for VUMC. "Partnering with Nashville Biosciences will greatly expand the national and global reach of these resources."


WEB:

Nashville Biosciences

 
Share:

Related Articles:


Recent Articles

Corker: PEPFAR Reauthorization Bill Passes Committee, Extends Successful U.S. Program to Combat HIV/AIDS

U.S. Senator Bob Corker (R-Tenn.), chairman of the Senate Foreign Relations Committee, today praised committee passage of legislation he authored with U.S. Senator Bob Menendez (D-N.J.) to extend the President's Emergency Plan for AIDS Relief (PEPFAR) for another five years.

Read More

TDH Issues Public Health Advisory On Cannabis

Evidence, Known Harms Increase Concerns about Risks to Health

Read More

HHS Secretary Addresses Nashville Health Care Council Audience

On Thursday, Sept. 27, Health and Human Services Secretary Alex M. Azar II flew to Nashville to share thoughts and updates on healthcare coverage in America during a Nashville Health Care Council Event held at Lipscomb University.

Read More

The War Against Opioids in Pain Management

Awareness, innovative therapies are effective tools to manage pain and ward against addiction.

Read More

Designed to Disinfect: The Relation Between Interior Design & Infection Control

About one in 25 patients in America has at least one healthcare-associated infection (HAI) on any given day, according to the most recent statistics from the Centers for Disease Control and Prevention.

Read More

Physician Spotlight: Changing Minds

Acadia Healthcare CMO Michael Genovese, MD, JD, tackles misconceptions around mental health and addiction.

Read More

Addressing the Gap Between Need & Access in Treating Addiction

Need far outstrips capacity when it comes to treating substance abuse disorders. American Addiction Centers CMO Dr. Lawrence Weinstein discusses barriers to care and possible solutions.

Read More

News of Note in Addiction

Tennessee Department of Health data show 1,776 Tennesseans died from drug overdoses in 2017, the highest annual number of such deaths since reporting began with prescription opioids leading the way.

Read More

Physicians, Healthcare Organizations Convene to Combat Tennessee's Opioid Crisis

Physicians and other healthcare professionals from around the state gathered in Nashville last month for education and updates on the opioid crisis and other pressing issues at the second annual TriMED Healthcare Education Summit.

Read More

Keeping the Focus on Quality & Safety

Quality and safety don't happen by accident. LifePoint Health has garnered national recognition for their commitment to quality and now shares their insights on sustained improvement with others.

Read More

Email Print
 
 

 

 


Tags:
Bioinformatics, Drug Development, Genomic Data, Leeland Ekstrom, Nashville Biosciences, Pharmaceutical Research, Vanderbilt University Medical Center, VUMC
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: